BioNxt Solutions Inc.
BNXTF
$0.25
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 100.00 | 100.00 | 11.50K | 15.80K | 16.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 100.00 | 100.00 | 11.50K | 15.80K | 16.70K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 100.00 | 100.00 | 11.50K | 15.80K | 16.70K |
| SG&A Expenses | 4.42M | 3.65M | 3.14M | 2.93M | 2.68M |
| Depreciation & Amortization | 12.90K | 8.00K | 21.10K | 34.00K | 45.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.96M | 4.23M | 3.76M | 3.81M | 3.55M |
| Operating Income | -4.96M | -4.23M | -3.75M | -3.80M | -3.54M |
| Income Before Tax | -6.84M | -5.16M | -4.47M | -4.38M | -4.15M |
| Income Tax Expenses | -141.60K | -141.60K | -64.10K | -64.10K | -64.10K |
| Earnings from Continuing Operations | -6.70 | -5.02 | -4.41 | -4.32 | -4.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.70M | -5.02M | -4.41M | -4.32M | -4.09M |
| EBIT | -4.96M | -4.23M | -3.75M | -3.80M | -3.54M |
| EBITDA | -4.95M | -4.21M | -3.71M | -3.74M | -3.47M |
| EPS Basic | -0.06 | -0.04 | -0.04 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.06 | -0.04 | -0.04 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 480.84M | 470.96M | 462.48M | 457.85M | 451.52M |
| Average Diluted Shares Outstanding | 480.84M | 470.96M | 462.48M | 457.85M | 451.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |